K223783

Substantially Equivalent

cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System

Applicant: Roche Molecular Systems, Inc.
Product code: QWR
Advisory panel: Microbiology
Date received: 2022-12-16
Decision date: 2023-12-04
Decision: Substantially Equivalent
Clearance type: Dual Track
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.